Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott Medical Devices
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who have national Medicare coverage by CMS
Symptomatic functional MR (≥3+) due to cardiomyopathy of either ischemic or non-ischemic etiology
Subject has been adequately treated per applicable standards, including for coronary artery disease, left ventricular dysfunction, mitral regurgitation and heart failure
Subject has had at least one hospitalization for heart failure in the 12 months prior to subject registration and/or a corrected BNP ≥300 pg/ml or corrected NT-proBNP ≥1500 pg/ml
New York Heart Association (NYHA) Functional Class II, III or ambulatory IV
Surgery will not be offered as a treatment option and medical therapy is the intended therapy for the subject
Left Ventricular Ejection Fraction (LVEF) is ≥20% and ≤50%
Left Ventricular End Systolic Dimension (LVESD) is ≤70 mm